Lisata Therapeutics, Inc. Profile Avatar - Palmy Investing

Lisata Therapeutics, Inc.

Lisata Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient …

Biotechnology
US, Basking Ridge [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Lisata Therapeutics, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Lisata Therapeutics, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Lisata Therapeutics, Inc..

End of LSTA's Analysis
CIK: - CUSIP: 128058302 ISIN: US1280583022 LEI: - UEI: -
Secondary Listings
LSTA has no secondary listings inside our databases.